This level of supervision enhances both the safety and effectiveness of GLP-1 therapy
[74] analyzed the FAERS data from 2005 to October 2023, revealing a notable incidence of suicidal ideation and depression linked to semaglutide and liraglutide, with no recorded cases of suicidal behaviors or completed suicides
The abdomen is an FDA-approved injection site for these medications, offering accessibility and consistent subcutaneous tissue
* Long-Lasting Delivery Designed to provide stable, gradual absorption for extended metabolic and appetite support
The decision to switch is personalized, considering individual health profiles, weight loss goals, lifestyle, and cost-effectiveness, ensuring the most suitable and affordable approach for each patient